This book chapter advances SDGs 3 and 17 by discussing available data regarding the effects of genetic variants on the clinical and pathological characteristics of “frontotemporal dementia” (FTD). The term “frontotemporal dementia” (FTD) defines a group of related diseases resulting from progressive degeneration of the temporal and frontal lobes. These areas play a significant role in decision-making, behavioral control, emotion, language, and motor functions.
This book chapter advances SDGs 3 and 17 by focusing on providing a brief overview of genes associated with sporadic (late-onset) Alzheimer's disease (AD). Despite decades of research, no current and reliable test is currently available for the diagnosis of AD. Genetic biomarkers are promising for both diagnostic tools and tailored profiling therapy.
This book chapter advances SDG 11, 13, 17 by describing the Intergovernmental Panel on Climate Change and other reports on the need to limit global temperature increase to 2.0°C and preferably 1.5°C. The chapter outlines possible scenarios and introduces the concept of “net zero” by 2050, the essential elimination of greenhouse gas emissions. The chapter also discusses why this deadline is not achievable and presents a more likely scenario.
This book chapter addresses SDGs 2 and 17 by explaining the past, present and future of food safety.
The health sector has an important role to play in terms of offering culturally appropriate and relevant care, tackling racism in the health care sector, improving engagement with Indigenous partners, and advocating for decolonizing policies that give control of health and wellness to the Indigenous people of Canada.
Elsevier,
Evidence-informed Approaches for Managing Dementia Transitions: Riding the Waves, Volume , 4 February 2020
This book chapter advances SDGs 3 and 17 by focusing on the need to establish equilibrium and well-being and is organized around eight themes using the acronym R-E-A-D-J-U-S-T. The chapter ties these themes with a call for more research and reinforcement for inclusion of the voices of people with dementia.
Elsevier,
Evidence-informed Approaches for Managing Dementia Transitions: Riding the Waves, Volume , 4 February 2020
This book chapter advances SDGs 3 and 17 by describing the prevalence of dementia in hospitalized patients, reasons for hospitalizations, and risks to older people with dementia in hospitals. Strategies for optimizing outcomes and models of care that are designed to improve care of persons with dementia and their care partners are described to assist healthcare team members working with this unique population.
Elsevier,
Evidence-informed Approaches for Managing Dementia Transitions: Riding the Waves, Volume , 4 February 2020
This book chapter advances SDGs 3 and 17 by introducing aspects of the lived experience, management, and epidemiology of dementia and some of the significant transitions that people with the disease and their caregivers frequently encounter.
Elsevier,
Neuroprotection in Autism, Schizophrenia and Alzheimer's disease, Volume , 16 October 2019
This book chapter advances SDGs 3 and 17 by reviewing a new promising neuroprotective approach to treating AZ, Tau-based therapies including tau-kinase inhibitors to acetylation inhibitors, microtubule stabilizers, aggregation inhibitors, monoclonal anti-tau antibodies or active tau vaccines. Special emphasis has been placed on the most promising therapeutic agents that have reached clinical trials.
This book chapter advances SDGs 3 and 17 by reviewing the neurochemical aspects of Alzheimer’s type of Dementia.
